Author Question: What makes a posttest only design a between subjects design? a. It has repeated measures. b. It ... (Read 91 times)

misspop

  • Hero Member
  • *****
  • Posts: 540
What makes a posttest only design a between subjects design?
 
  a. It has repeated measures.
  b. It uses a filler task as a control.
  c. Different participants are assigned to the treatment and control conditions.
  d. It makes use of a one-tailed hypothesis.

Question 2

If you were manipulating the type of scenario (story) read by participants before performing a memory task, what task would be appropriate for the control group? They should
 
  a. read an equivalent story, but one that lacked the critical feature of the experimental story
  b. read exactly the same story as the experimental participants read
  c. take a placebo
  d. do nothing during this phase of the experiment



xthemafja

  • Sr. Member
  • ****
  • Posts: 348
Answer to Question 1

C
In any between subjects design, there are different participants or subjects in the control and treatment conditions.

Answer to Question 2

A
Control tasks should be as similar to the experimental task as possible while still permitting the manipulation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

A good example of polar molecules can be understood when trying to make a cake. If water and oil are required, they will not mix together. If you put them into a measuring cup, the oil will rise to the top while the water remains on the bottom.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library